1. Home
  2. TRIB vs GRNQ Comparison

TRIB vs GRNQ Comparison

Compare TRIB & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRIB
  • GRNQ
  • Stock Information
  • Founded
  • TRIB 1992
  • GRNQ 2013
  • Country
  • TRIB Ireland
  • GRNQ Malaysia
  • Employees
  • TRIB N/A
  • GRNQ N/A
  • Industry
  • TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GRNQ EDP Services
  • Sector
  • TRIB Health Care
  • GRNQ Technology
  • Exchange
  • TRIB Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • TRIB 13.0M
  • GRNQ 12.7M
  • IPO Year
  • TRIB N/A
  • GRNQ 2018
  • Fundamental
  • Price
  • TRIB $0.67
  • GRNQ $1.60
  • Analyst Decision
  • TRIB
  • GRNQ
  • Analyst Count
  • TRIB 0
  • GRNQ 0
  • Target Price
  • TRIB N/A
  • GRNQ N/A
  • AVG Volume (30 Days)
  • TRIB 2.4M
  • GRNQ 85.9K
  • Earning Date
  • TRIB 08-13-2025
  • GRNQ 08-12-2025
  • Dividend Yield
  • TRIB N/A
  • GRNQ N/A
  • EPS Growth
  • TRIB N/A
  • GRNQ N/A
  • EPS
  • TRIB N/A
  • GRNQ N/A
  • Revenue
  • TRIB $61,555,000.00
  • GRNQ $3,190,761.00
  • Revenue This Year
  • TRIB $13.51
  • GRNQ N/A
  • Revenue Next Year
  • TRIB $13.14
  • GRNQ N/A
  • P/E Ratio
  • TRIB N/A
  • GRNQ N/A
  • Revenue Growth
  • TRIB 8.31
  • GRNQ N/A
  • 52 Week Low
  • TRIB $0.48
  • GRNQ $0.80
  • 52 Week High
  • TRIB $3.44
  • GRNQ $2.24
  • Technical
  • Relative Strength Index (RSI)
  • TRIB 48.68
  • GRNQ 56.94
  • Support Level
  • TRIB $0.60
  • GRNQ $1.47
  • Resistance Level
  • TRIB $0.87
  • GRNQ $1.70
  • Average True Range (ATR)
  • TRIB 0.08
  • GRNQ 0.18
  • MACD
  • TRIB 0.01
  • GRNQ -0.01
  • Stochastic Oscillator
  • TRIB 33.94
  • GRNQ 48.19

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

Share on Social Networks: